Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
345.37
+5.71 (1.68%)
At close: Oct 23, 2026, 4:00 PM EDT
345.00
-0.37 (-0.11%)
After-hours: Oct 23, 2026, 7:57 PM EDT

CRL Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, CRL stock has a consensus rating of "Buy" and an average price target of $314.2. The average 1-year stock price forecast is 9.03% lower than the current stock price, while the lowest is $145 (-58.02%) and the highest is $357 (+3.37%).

Price Target: $314.2 (-9.03%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$145$314.2$325$357
Change-58.02%-9.03%-5.90%+3.37%

Analyst Ratings

The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy1010991111
Buy343443
Hold323222
Sell100000
Strong Sell011111
Total171716161817

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$310 → $345
BuyMaintains$310 → $345-0.11%Oct 17, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$300 → $340
BuyReiterates$300 → $340-1.55%Oct 12, 2026
RBC Capital
RBC Capital
Buy
Maintains
$322
BuyMaintains$322-6.77%Oct 7, 2026
UBS
UBS
Buy
Initiates
$357
BuyInitiates$357+3.37%Sep 30, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
n/a
BuyReiteratesn/an/aSep 28, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.92B
from 4.02B
Decreased by -2.45%
Revenue Next Year
4.02B
from 3.92B
Increased by 2.53%
EPS This Year
11.38
from 10.28
Increased by 10.66%
EPS Next Year
12.75
from 11.38
Increased by 12.05%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 25, 2021Dec 31, 2022Dec 30, 2023Dec 28, 2024Dec 27, 2025Dec 31, 2026
Revenue
3.54B3.98B4.13B4.05B4.02B3.92B
Revenue Growth
21.08%12.31%3.86%-1.92%-0.85%-2.45%
Gross Profit
1.34B1.47B1.53B1.41B1.40B1.35B
Gross Margin
37.78%36.91%37.03%34.76%34.98%34.39%
Operating Income
634.39M665.51M648.89M545.86M497.76M822.53M
Net Income
390.98M486.23M474.62M22.20M-144.34M187.02M
EPS
----10.2811.38
EPS Growth
-----0.39%10.66%
Forward PE
33.7219.6622.7418.5319.3230.36
Free Cash Flow
----518.49M301.05M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.0B
Avg3.9B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
-1.4%
Avg
-2.4%
Low
-2.8%

EPS Forecast

EPS202620272028
High11.49
Avg11.38
Low11.02

EPS Growth

EPS Growth202620272028
High
11.8%
Avg
10.7%
Low
7.2%